INVESTORS
News Releases
Webcasts
SEC Filings
Corporate Governance
Annual Reports
Stock Info
Investor FAQ
Email Alerts
Information Requests
Analyst Coverage
Contact Information

CORPORATE
Management Team
Board of Directors
Scientific Advisory Board
History

TUMOR HYPOXIA

PRODUCT PIPELINE
TH-302 (Hypoxia-Activated Prodrug)
Glufosfamide
2-Deoxyglucose (2DG)

CLINICAL TRIALS
Various Cancers
Pancreatic Cancer
Soft Tissue Sarcoma
Ovarian Cancer

CAREERS
Current Opportunities
Benefits